Global Cardiology Market 2022-2028
The cardiology market which includes cardiology devices (excluding diagnostics and imaging), surgeries and drugs is growing with a CAGR of 6.3% for the forecasted period of 2021-2021. The market is mainly driven by impending burden of cardiovascular diseases on global population and economy. The economic burden is over $800 billion annually and may rise over $1 trillion by 2030. Cardiovascular diseases are the number one cause of death globally. CVDs are responsible for over 3 million deaths annually which is 30% of total death due to non-communicable diseases. Some of the major CVDs include coronary heart diseases, stroke, hypertensive heart diseases, inflammatory heart diseases, rheumatoid heart diseases and others.Coronary heart diseases are the leading cause of death followed by strokes. The prevalence and incidence rate of heart diseases are on a rise; especially in major emerging countries such as India, China and Japan. Another major factor driving the market is medical tourism. Especially in emerging markets such as India, ASEAN countries and China, the cost of surgery and treatment for cardiovascular diseases is low. In India a heart surgery may costs around 1,500 including pre and post-surgery costs whereas in the United States it costs 5 to 10 times. Hence, many Americans prefer to travel to India for their treatment. Same trend has been witnessed in major developed countries.
There has been significant improvement in terms of technologies and innovation. New methods are being developed to reduce the cost of surgeries and prevent any major mistakes. Robotic surgical arms, minimally invasive surgeries and hybrid operating room are helping health professionals to provide better services. Currently, these new innovations are costly; however, with rise in demand there will be significant fall in the prices.
The market for devices includes angioplasty balloons, stents, catheters, cardiac rhythm management devices such as defibrillators and pacemakers, ventricular assistive devices and other cardiology devices such as guidewires and cannulas.
- Chapter 1. Report Summary
- 1.1. Research Methods And Tools
- 1.2. Market Breakdown
- 1.2.1. By Segments
- 1.2.2. By Geography
- 1.2.3. By Stakeholders
- Chapter 2. Market Overview And Insights
- 2.1. Gap Analysis
- 2.2. Analyst & Current Market Trends
- 2.2.1. Key Findings
- 2.2.1.1. Increasing Trend Of Minimally Invasive Technology
- 2.2.1.2. Growing Aneursym Repair Surgery Market
- 2.2.1.3. Increasing Market Of Antidotes Drugs
- 2.2.1.4. Low Cost Treatment In The Emerging Economies
- 2.2.2. Recommendation
- 2.2.3. Conclusion
- 2.3. Regulations
- 2.3.1. Tax Laws
- 2.3.1.1. United States
- 2.3.1.2. European Union
- 2.3.1.3. China
- 2.3.1.4. India
- 2.3.2. Drugs And Device Regulations
- 2.3.2.1. United States
- 2.3.2.2. European Union
- 2.3.2.3. China
- 2.3.2.4. India
- 2.3.2.5. Rest Of The World
- 2.4. Type Of Cardiovascular Diseases
- 2.4.1. Coronary Heart Diseases
- 2.4.2. Stroke
- 2.4.3. Hypertensive Heart Diseases
- 2.4.4. Inflammatory Heart Diseases
- 2.4.5. Rheumatic Heart Diseases
- 2.4.6. Other Heart Diseases
- Chapter 3. Market Determinant
- 3.1. Motivators
- 3.1.1. Increasing Incidence And Prevalence Of Cardiovascular Diseases
- 3.1.2. Medical Tourism In Emerging Market
- 3.1.3. Innovations And Development Of New Products
- 3.1.4. Availability Of Remote Monitoring Solutions
- 3.1.5. Rising Healthcare Expenditure
- 3.2. Restraints
- 3.2.1. High Cost Of Surgeries And Medical Devices In Both Developed And Emerging Markets
- 3.2.2. Strict Government Policies
- 3.3. Opportunities
- 3.3.1. Emerging Markets
- 3.3.2. Growing Hybrid Operating Rooms Market
- Chapter 4. Market Segmentation
- 4.1. By Cardiology Devices Types
- 4.1.1. Angioplasty
- 4.1.2. Cardiovascular Stents
- 4.1.3. Cardiovascular Catheters
- 4.1.4. Cardiac Rhythm Management
- 4.1.5. Cardiovascular Assistive Devices
- 4.2. By Cardiology Drugs Types
- 4.2.1. Antithrombotic Drugs
- 4.2.2. Antidyslipidemic Drugs
- 4.2.3. Antihypertensive Drugs
- 4.2.4. Anti Stroke Drugs
- 4.3. By Cardiology Drugs By Mechanism
- 4.3.1. Beta Blockers
- 4.3.2. Beta Agonists
- 4.3.3. Alpha Blockers
- 4.3.4. Alpha Agonists
- 4.3.5. Sodium Channel Blockers
- 4.3.6. Calcium Channel Blockers
- 4.3.7. Vasodilators
- 4.3.8. Renin Inhibitors
- 4.3.9. Angiotensin Receptor Blockers
- 4.3.10. Diuretics
- 4.3.11. Thrombolytics
- 4.4. By Cardiology Surgeries Types
- 4.4.1. Coronary Artery Bypass Grafting
- 4.4.2. Transmyocardial Laser Revascularization
- 4.4.3. Heart Valve Repair
- 4.4.4. Arrhythmia Treatment
- 4.4.5. Aneurysm Repair
- 4.4.6. Heart Transplant
- Chapter 5. Competitive Landscape
- 5.1. Key Strategies
- Chapter 6. Regional Analysis
- 6.1. North America
- 6.1.1. United States
- 6.1.2. Canada
- 6.2. Europe
- 6.2.1. United Kingdom
- 6.2.2. France
- 6.2.3. Germany
- 6.2.4. Italy
- 6.2.5. Spain
- 6.3. Asia Pacific
- 6.3.1. India
- 6.3.2. China
- 6.3.3. Japan
- 6.3.4. Rest Of Asia Pacific
- 6.4. Rest Of The World
- Chapter 7. Company Profiles
- 7.1. Pfizer
- 7.1.1. Introduction
- 7.1.2. Product Portfolio
- 7.1.3. Recent Activities
- 7.2. Sanofi S.A.
- 7.2.1. Introduction
- 7.2.2. Product Portfolio
- 7.2.3. Recent Activities
- 7.3. Astrazeneca
- 7.3.1. Introduction
- 7.3.2. Product Portfolio
- 7.3.3. Recent Activities
- 7.4. Novartis
- 7.4.1. Introduction
- 7.4.2. Product Portfolio
- 7.4.3. Recent Activities
- 7.5. Bristol-myers Squibb
- 7.5.1. Introduction
- 7.5.2. Product Portfolio
- 7.5.3. Recent Activities
- 7.6. 6. Merck
- 7.6.1. Introduction
- 7.6.2. Product Portfolio
- 7.6.3. Recent Activities
- 7.7. Boston Scientific Corporation
- 7.7.1. Introduction
- 7.7.2. Product Portfolio
- 7.8. Medtronic
- 7.8.1. Introduction
- 7.8.2. Product Portfolio
- 7.8.3. Recent Activities
- 7.9. St. Jude Medical
- 7.9.1. Introduction
- 7.9.2. Product Portfolio
- 7.9.3. Recent Activities
- 7.10. Cook Medical
- 7.10.1. Introduction
- 7.10.2. Product Portfolio
- 7.10.3. Recent Activities
- 7.11. Cr Bard Inc.
- 7.11.1. Introduction
- 7.11.2. Product Portfolio
- 7.12. Sun Pharma
- 7.12.1. Introduction
- 7.12.2. Product Portfolio
- 7.12.3. Recent Activities
- 7.13. Ge Healthcare
- 7.13.1. Introduction
- 7.13.2. Product Portfolio
- 7.13.3. Recent Activities
- 7.14. Johnson & Johnson
- 7.14.1. Introduction
- 7.14.2. Product Portfolio
- 7.14.3. Recent Developments
- 7.15. Takeda Pharmaceutical Company Ltd
- 7.15.1. Introduction
- 7.15.2. Product Portfolio
- 7.16. Daiichi Sankyo Co. Ltd.
- 7.16.1. Introduction
- 7.16.2. Product Portfolio
- 7.17. F. Hoffmann-la Roche Ltd
- 7.17.1. Introduction
- 7.17.2. Product Portfolio
- 7.18. Bayer Ag
- 7.18.1. Introduction
- 7.18.2. Product Portfolio
- 7.18.3. Recent Activities
- 7.19. Boehringer Ingelheim
- 7.19.1. Introduction
- 7.19.2. Product Portfolio
- 7.20. Otsuka
- 7.20.1. Introduction
- 7.20.2. Product Portfolio
Research Assistance
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook